If you made any changes in Pure these will be visible here soon.

Research Output 2005 2019

Filter
Meeting Abstract
2018

Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study: Blood 2018 132:459

Yeung, D. T., Grigg, A. P., Shanmuganathan, N., Cunningham, I., Shortt, J., Rowlings, P., Reynolds, J., Cushion, R., Harrup, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C., Schwarer, A. P., Jackson, K., Viiala, N., Weinkove, R., Yong, A., White, D. L., Branford, S. & 1 others, Hughes, T. P., Nov 2018, In : Blood. 132, Suppl 1, p. 459-459 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis

Bergin, K., Yuen, F., Wallington-Beddoe, C. T., Kalff, A., Sirdesai, S., Reynolds, J. & Spencer, A., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3265.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Pomalidomide Alone or in Combination with Low Dose Dexamethasone As Maintenance Following Induction with Pomalidomide and Low Dose Dexamethasone in Relapsed and Refractory Myeloma (ALLG MM14)

Kalff, A., Kennedy, N., Reynolds, J., Quach, H., Ho, P. J., Horvath, N., Mollee, P., D'Rozario, J. M., Taylor, K., Estell, J. & Spencer, A., 21 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 1986.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy: Blood 2018 132:3279

Spencer, A., Quach, H., Horvath, N., Kerridge, I. H., Yuen, F., Lee, E. S-H., Morris, E. S., Kalff, A., Bergin, K., Sirdesai, S., Gorniak, M., Mithraprabhu, S., Khong, T. & Reynolds, J., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3279.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2017

Identification of Acetylation, Immune Cell Alterations and Gene Signature As Dynamic Biomarkers of Response to Panobinostat Treatment in Multiple Myeloma Patients

Mithraprabhu, S., Savvidou, I., Ramachandran, M., Kalff, A., Khong, T. T., Reed, K., Reynolds, J. & Spencer, A., 7 Dec 2017, In : Blood. 130, Suppl 1, 1 p., 1823.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Nilotinib in Combination with Pegylated Interferon Alfa-2b for CP-CML Leads to High Molecular Response Rates: Interim Results of the Pinnacle Study: Blood 2017 130:2898

Yeung, D., Grigg, A., Shanmuganathan, N., Cunningham, I., Shortt, J., Rowling, P., Reynolds, J., Cushion, R., Harrap, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C. K., Schwarer, A. P., Jackson, K., Viiala, N., Weinkove, R., Yong, A. S. M., White, D. L., Branford, S. & 1 others, Hughes, T. P., 7 Dec 2017, In : Blood. 130, Suppl 1, 2898.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Red Cell Alloimmunisation Is Associated with Development of Autoantibodies and Increased Red Cell Transfusion Requirements in Myelodysplastic Syndromes (MDS)

Singhal, D., Kutyna, M. M., Chhetri, R., Wee, A., Hague, S., Nath, L., Nath, S. V., Sinha, R., Wickham, N., Lewis, I. D., Ross, D. M., Bardy, P. G., To, L. B., Reynolds, J., Wood, E., Roxby, D. J. & Hiwase, D. K., 7 Dec 2017, In : Blood. 130, Suppl 1, p. 2411 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2016

RBC-Transfusion Dependency Improves the Prognostic Value of the Revised-IPSS in MDS Patients: Analysis of South Australian and Dusseldorf MDS Registries

Singhal, D., Strupp, C., Chhetri, R., Kutyna, M. M., Wee, L. A., Nath, S. V., Wickham, N., Hui, C., Gray, J. X., Ross, D. M., Lewis, I. D., Bardy, P. G., Reynolds, J., To, L. B., Hiwase, D. K. & Germing, U., 2 Dec 2016, In : Blood. 128, 22, 1 p., 1998.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Roar: A Phase Ib Trial of Oral Azacitidine (CC-486) in Combination with Lenalidomide and Dexamethasone (Rd) for Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma Who Have Failed a Prior Lenalidomide-Containing Regimen

Kalff, A., Reed, K., Khong, T. T., Mithraprabhu, S., Ramachandran, M., Reynolds, J., Bergin, K., Thakurta, A., Wang, M., Spencer, A., Guzman, R., Cuoto, S. & Ren, Y., 2 Dec 2016, In : Blood. 128, 22, 1 p., 2121.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

TOP2A a New Predictive Marker of Response to Carfilzomib in Multiple Myeloma

Reale, A., Khong, T., Mithraprabhu, S., Reynolds, J., Ramachandran, M., Savvidou, I., Bergin, K., Hocking, J. & Spencer, A., 2 Dec 2016, In : Blood. 128, 22, 1 p., 4461.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2011

Complete Molecular Response (CMR) Rate with Nilotinib in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) without CMR After ≥ 2 Years on Imatinib: Preliminary Results From the Randomized ENESTcmr Trial of Nilotinib 400 Mg Twice Daily (BID) Vs Imatinib

Hughes, T. P., Lipton, J. H., Leber, B., Spector, N., Cervantes, F., Pasquini, R., Clementino, N., Schwarer, A. P., Mahon, F-X., Rea, D., Yeung, D. T., Kamel-Reid, S., Bendit, I., Reynolds, J., Williams, L., Szczudlo, T. & Branford, S., 18 Nov 2011, In : Blood. 118, 21, 606.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2009

International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

Deininger, M., O'Brien, S. G., Guilhot, F., Goldman, J. M., Hochhaus, A., Hughes, T. P., Radich, J. P., Hatfield, A. K., Mone, M., Filian, J., Reynolds, J., Larson, R. A., Gathmann, I. & Druker, B. J., 20 Nov 2009, In : Blood. 114, 22, 1126.

Research output: Contribution to journalMeeting AbstractOtherpeer-review